SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934
BLACKROCK HEALTH SCIENCES TRUST II
(Exact Name of Registrant as Specified in its Charter)
| Maryland | 84-3283144 | |
| (State of Incorporation or Organization) | (IRS Employer Identification Number) | |
100 Bellevue Parkway Wilmington, Delaware | 19809 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. ☒
If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ☐
Securities Act registration statement file number to which this form relates:
333-233373
Securities to be registered pursuant to Section 12(b) of the Act:
Title of Each Class to be so Registered | Name of Each Exchange on Which Each Class is to be Registered | |
| Common Shares of Beneficial Interest | New York Stock Exchange |
Securities to be registered pursuant to Section 12(g) of the Act:
None
INFORMATION REQUIRED IN REGISTRATION STATEMENT
| Item 1. | Description of Registrant’s Securities to be Registered. |
The description of the Registrant’s securities to be registered is incorporated by reference to the description contained under the caption “Description of Shares” in the Registrant’s Registration Statement on FormN-2 (Nos.333-233373 and811-23466) as filed electronically with the Securities and Exchange Commission (the “Commission”) on August 20, 2019 (AccessionNo. 0001193125-19-225192) (“Registration Statement on FormN-2”), as amended byPre-Effective Amendment No. 1 to the Registration Statement on FormN-2, as filed with the Commission on December 9, 2019 (AccessionNo. 0001193125-19-308635) andPre-Effective Amendment No. 2 to the Registration Statement on FormN-2, as filed with the Commission on December 30, 2019 (AccessionNo. 0001193125-19-326014).
| Item 2. | Exhibits. |
Pursuant to the Instructions as to Exhibits, no exhibits are filed herewith or incorporated by reference.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
BLACKROCK HEALTH SCIENCES TRUST II
Date: January 21, 2020 | ||
| By: | /s/ Neal J. Andrews | |
| Name: | Neal J. Andrews | |
| Title: | Chief Financial Officer | |
Signature Page to Form8-A of BlackRock Health Sciences Trust II
